HySum New Materials participated in Pharma Asia 2025, one of the most influential pharmaceutical industry exhibitions along the Belt and Road route. The event gathers global professionals and supply-chain partners, serving as a vital bridge for Chinese enterprises expanding into South Asia and the Middle East.
Rising Demand for High-Barrier, Safer, and More Stable Pharmaceutical Packaging in South Asia


With the continuous advancement of the Belt and Road cooperation, Pakistan and neighboring countries are accelerating the upgrade of their pharmaceutical manufacturing capabilities.
This development is driving strong demand for:
-
High-barrier pharmaceutical packaging
-
Safer and more compliant materials
-
Stable, high-performance drug protection solutions
Leveraging its global footprint, deep technical expertise, and long-term commitment to high-barrier flexible packaging, HySum is entering a new window of opportunity in the South Asian market.
Showcasing Core High-Barrier Pharmaceutical Packaging Materials

At Pharma Asia 2025, HySum highlighted its leading portfolio of pharmaceutical packaging solutions, including:
-
Cold Stamped Aluminum (Deep-Drawing Cold Aluminum)
-
Tropical Blister Aluminum
-
PTP Pharmaceutical Aluminum Foil
-
High-Barrier Laminating Films / High-Barrier Composite Film
-
PVC/PVDC high-barrier rigid sheet
-
PET/PVDC high-barrier rigid sheet
These materials are widely used in solid dosage packaging, moisture-proof and oxygen-barrier applications, and scenarios requiring strict pharmaceutical compliance across multiple Belt and Road countries.
Their advantages—strong barrier performance, strong stability, and strong suitability—continue to earn positive attention from customers.
Expanding Global Collaboration Through Continuous Participation in Belt and Road Markets
As a company committed to “providing quality packaging for quality medicines,” HySum has actively participated in pharmaceutical exhibitions in Bangladesh, Malaysia, Russia, Egypt, and other Belt and Road countries over the past year.
These engagements help HySum strengthen its international cooperation network, enhance its understanding of regional pharmaceutical needs, and accelerate global resource integration.
Pharma Asia 2025 represents yet another steady expansion of HySum’s long-term involvement in South Asia’s pharmaceutical supply chain—an important strategic practice following global development trends under the Belt and Road Initiative, supporting sustained growth of international business.
Supporting Belt and Road Countries with Quality Packaging, Reliable Supply, and Professional Service
Looking ahead, HySum New Materials will continue advancing into Belt and Road partner countries with:
-
High-quality pharmaceutical packaging materials
-
Reliable and stable supply-chain capabilities
-
A professional, responsive service system
HySum remains committed to supporting Belt and Road countries in building safer, higher-quality, and more resilient pharmaceutical value chains.
